Related Experiment Video
Updated: May 12, 2026

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
Association of diabetes with amnestic and nonamnestic mild cognitive impairment
Rosebud O Roberts1, David S Knopman2, Yonas E Geda3
1Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA; Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Background:
Type 2 diabetes may increase the risk of amnestic mild cognitive impairment (aMCI) through Alzheimer's disease (AD)-related and vascular pathology and may also increase the risk of nonamnestic MCI (naMCI) through vascular disease mechanisms. We examined the association of type 2 diabetes with mild cognitive impairment (MCI) and MCI subtype (aMCI and naMCI) overall and by sex.
Methods:
Participants were Olmsted County, Minnesota residents (70 years and older) enrolled in a prospective, population-based study. At baseline and every 15 months thereafter, participants were evaluated using the Clinical Dementia Rating scale, a neurological evaluation, and neuropsychological testing for a diagnosis of normal cognition, MCI, and dementia by a consensus panel. Type 2 diabetes was ascertained from the medical records of participants at baseline.
Results:
Over a median 4.0 years of follow-up, 348 of 1450 subjects developed MCI. Type 2 diabetes was associated (hazard ratio [95% confidence interval]) with MCI (1.39 [1.08-1.79]), aMCI (1.58 [1.17-2.15]; multiple domain: 1.58 [1.01-2.47]; single domain: 1.49 [1.09-2.05]), and the hazard ratio for naMCI was elevated (1.37 [0.84-2.24]). Diabetes was strongly associated with multiple-domain aMCI in men (2.42 [1.31-4.48]) and an elevated risk of multiple domain naMCI in men (2.11 [0.70-6.33]), and with single domain naMCI in women (2.32 [1.04-5.20]).
Conclusions:
Diabetes was associated with an increased risk of MCI in elderly persons. The association of diabetes with MCI may vary with subtype, number of domains, and sex. Prevention and control of diabetes may reduce the risk of MCI and Alzheimer's disease.
Insights
Type 2 diabetes increases the risk of mild cognitive impairment (MCI) in older adults. This association varies by MCI subtype, affected cognitive domains, and sex, highlighting the need for diabetes management to prevent cognitive decline.
Area of Science:
- Neurology
- Endocrinology
- Geriatrics
Background:
- Type 2 diabetes is linked to Alzheimer's disease and vascular pathology, potentially increasing risks for amnestic MCI (aMCI) and nonamnestic MCI (naMCI).
- Understanding the specific associations between type 2 diabetes and MCI subtypes is crucial for targeted prevention strategies.
Purpose of the Study:
- To investigate the association between type 2 diabetes and mild cognitive impairment (MCI) in an elderly population.
- To examine how type 2 diabetes relates to specific MCI subtypes: amnestic MCI (aMCI) and nonamnestic MCI (naMCI), considering sex differences.
Main Methods:
- A prospective, population-based study of Olmsted County residents aged 70 years and older.
- Participants underwent regular neurological and neuropsychological evaluations for diagnosis of normal cognition, MCI, or dementia.
- Type 2 diabetes status was determined from baseline medical records.
Main Results:
- Over a median of 4.0 years, type 2 diabetes was associated with an increased risk of MCI (HR 1.39).
- Diabetes showed a significant association with aMCI (HR 1.58), particularly multiple-domain aMCI (HR 1.58) and single-domain aMCI (HR 1.49).
- Sex-specific associations were observed, with stronger links to multiple-domain aMCI in men and single-domain naMCI in women.
Conclusions:
- Type 2 diabetes is associated with a higher risk of MCI in the elderly population.
- The relationship between diabetes and MCI is complex, influenced by MCI subtype, cognitive domain involvement, and sex.
- Effective diabetes management may play a role in reducing the risk of MCI and Alzheimer's disease.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Alzheimer Disease l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia
The progression of dementia is generally gradual.
Psychoneuroimmunology: Diabetes and Cancer
Amnesia
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...

